Drug industry antitrust act.

Hearings before the Subcommittee on Antitrust and Monopoly of the Committee on the Judiciary, United States Senate, Eighty-seventh Congress, first [-second] session, pursuant to S. Res. 52 on S. 1552, a bill to amend and supplement the antitrust laws, with respect to the manufacture and distribution of drugs, and for other purposes.

Drug industry antitrust act.
United States. Congress. Senat ...
Locate

My Reading Lists:

Create a new list


Buy this book

Last edited by MARC Bot
March 30, 2025 | History

Drug industry antitrust act.

Hearings before the Subcommittee on Antitrust and Monopoly of the Committee on the Judiciary, United States Senate, Eighty-seventh Congress, first [-second] session, pursuant to S. Res. 52 on S. 1552, a bill to amend and supplement the antitrust laws, with respect to the manufacture and distribution of drugs, and for other purposes.

This work doesn't have a description yet. Can you add one?

Publish Date
Language
English

Buy this book

Book Details


Edition Notes

Available also in microform in CIS US congressional committee hearings, accession number (87)S1489-0-A through C(pts.1-3), (87)S1494-2-A through C(pts.4-6), (87)S1501(pt.7).
Includes bibliographies.
Hearings held July 5, 1961.

Published in
Washington

Classifications

Library of Congress
KF26 .J8 1961a, HD9665.7.U6 F61

The Physical Object

Pagination
pts.

Edition Identifiers

Open Library
OL5842253M
LCCN
61064832
OCLC/WorldCat
2955837

Work Identifiers

Work ID
OL656802W

Community Reviews (0)

No community reviews have been submitted for this work.

Lists

Download catalog record: RDF / JSON